0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ADC Drug Substance Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-33G17874
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global ADC Drug Substance Market Research Report 2024
BUY CHAPTERS

Global ADC Drug Substance Market Research Report 2025

Code: QYRE-Auto-33G17874
Report
April 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

ADC Drug Substance Market

The global market for ADC Drug Substance was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for ADC Drug Substance is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for ADC Drug Substance is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of ADC Drug Substance include TOT Biopharm International, Lonza Group AG, WuXi XDC Cayman, BrightGene Bio-Medical, Haoyuan Pharmaceutical, Pfizer, Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for ADC Drug Substance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADC Drug Substance.
The ADC Drug Substance market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ADC Drug Substance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADC Drug Substance manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of ADC Drug Substance Market Report

Report Metric Details
Report Name ADC Drug Substance Market
by Type
  • ADC Drug Substance Targeting Nectin-4
  • ADC Drug Substance Targeting Trop-2
by Application
  • Drug R&D
  • Medical Research
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company TOT Biopharm International, Lonza Group AG, WuXi XDC Cayman, BrightGene Bio-Medical, Haoyuan Pharmaceutical, Pfizer, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of ADC Drug Substance manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of ADC Drug Substance by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of ADC Drug Substance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the ADC Drug Substance Market report?

Ans: The main players in the ADC Drug Substance Market are TOT Biopharm International, Lonza Group AG, WuXi XDC Cayman, BrightGene Bio-Medical, Haoyuan Pharmaceutical, Pfizer, Roche

What are the Application segmentation covered in the ADC Drug Substance Market report?

Ans: The Applications covered in the ADC Drug Substance Market report are Drug R&D, Medical Research, Others

What are the Type segmentation covered in the ADC Drug Substance Market report?

Ans: The Types covered in the ADC Drug Substance Market report are ADC Drug Substance Targeting Nectin-4, ADC Drug Substance Targeting Trop-2

Recommended Reports

Drug Screening Trends

Cardiovascular Drugs

Pharmaceutical Equipment

1 ADC Drug Substance Market Overview
1.1 Product Definition
1.2 ADC Drug Substance by Type
1.2.1 Global ADC Drug Substance Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 ADC Drug Substance Targeting Nectin-4
1.2.3 ADC Drug Substance Targeting Trop-2
1.3 ADC Drug Substance by Application
1.3.1 Global ADC Drug Substance Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Drug R&D
1.3.3 Medical Research
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global ADC Drug Substance Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global ADC Drug Substance Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global ADC Drug Substance Production Estimates and Forecasts (2020-2031)
1.4.4 Global ADC Drug Substance Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global ADC Drug Substance Production Market Share by Manufacturers (2020-2025)
2.2 Global ADC Drug Substance Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of ADC Drug Substance, Industry Ranking, 2023 VS 2024
2.4 Global ADC Drug Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global ADC Drug Substance Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of ADC Drug Substance, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of ADC Drug Substance, Product Offered and Application
2.8 Global Key Manufacturers of ADC Drug Substance, Date of Enter into This Industry
2.9 ADC Drug Substance Market Competitive Situation and Trends
2.9.1 ADC Drug Substance Market Concentration Rate
2.9.2 Global 5 and 10 Largest ADC Drug Substance Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 ADC Drug Substance Production by Region
3.1 Global ADC Drug Substance Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global ADC Drug Substance Production Value by Region (2020-2031)
3.2.1 Global ADC Drug Substance Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of ADC Drug Substance by Region (2026-2031)
3.3 Global ADC Drug Substance Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global ADC Drug Substance Production Volume by Region (2020-2031)
3.4.1 Global ADC Drug Substance Production by Region (2020-2025)
3.4.2 Global Forecasted Production of ADC Drug Substance by Region (2026-2031)
3.5 Global ADC Drug Substance Market Price Analysis by Region (2020-2025)
3.6 Global ADC Drug Substance Production and Value, Year-over-Year Growth
3.6.1 North America ADC Drug Substance Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe ADC Drug Substance Production Value Estimates and Forecasts (2020-2031)
3.6.3 China ADC Drug Substance Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan ADC Drug Substance Production Value Estimates and Forecasts (2020-2031)
4 ADC Drug Substance Consumption by Region
4.1 Global ADC Drug Substance Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global ADC Drug Substance Consumption by Region (2020-2031)
4.2.1 Global ADC Drug Substance Consumption by Region (2020-2025)
4.2.2 Global ADC Drug Substance Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America ADC Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America ADC Drug Substance Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe ADC Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe ADC Drug Substance Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific ADC Drug Substance Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific ADC Drug Substance Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa ADC Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa ADC Drug Substance Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global ADC Drug Substance Production by Type (2020-2031)
5.1.1 Global ADC Drug Substance Production by Type (2020-2025)
5.1.2 Global ADC Drug Substance Production by Type (2026-2031)
5.1.3 Global ADC Drug Substance Production Market Share by Type (2020-2031)
5.2 Global ADC Drug Substance Production Value by Type (2020-2031)
5.2.1 Global ADC Drug Substance Production Value by Type (2020-2025)
5.2.2 Global ADC Drug Substance Production Value by Type (2026-2031)
5.2.3 Global ADC Drug Substance Production Value Market Share by Type (2020-2031)
5.3 Global ADC Drug Substance Price by Type (2020-2031)
6 Segment by Application
6.1 Global ADC Drug Substance Production by Application (2020-2031)
6.1.1 Global ADC Drug Substance Production by Application (2020-2025)
6.1.2 Global ADC Drug Substance Production by Application (2026-2031)
6.1.3 Global ADC Drug Substance Production Market Share by Application (2020-2031)
6.2 Global ADC Drug Substance Production Value by Application (2020-2031)
6.2.1 Global ADC Drug Substance Production Value by Application (2020-2025)
6.2.2 Global ADC Drug Substance Production Value by Application (2026-2031)
6.2.3 Global ADC Drug Substance Production Value Market Share by Application (2020-2031)
6.3 Global ADC Drug Substance Price by Application (2020-2031)
7 Key Companies Profiled
7.1 TOT Biopharm International
7.1.1 TOT Biopharm International ADC Drug Substance Company Information
7.1.2 TOT Biopharm International ADC Drug Substance Product Portfolio
7.1.3 TOT Biopharm International ADC Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.1.4 TOT Biopharm International Main Business and Markets Served
7.1.5 TOT Biopharm International Recent Developments/Updates
7.2 Lonza Group AG
7.2.1 Lonza Group AG ADC Drug Substance Company Information
7.2.2 Lonza Group AG ADC Drug Substance Product Portfolio
7.2.3 Lonza Group AG ADC Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Lonza Group AG Main Business and Markets Served
7.2.5 Lonza Group AG Recent Developments/Updates
7.3 WuXi XDC Cayman
7.3.1 WuXi XDC Cayman ADC Drug Substance Company Information
7.3.2 WuXi XDC Cayman ADC Drug Substance Product Portfolio
7.3.3 WuXi XDC Cayman ADC Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.3.4 WuXi XDC Cayman Main Business and Markets Served
7.3.5 WuXi XDC Cayman Recent Developments/Updates
7.4 BrightGene Bio-Medical
7.4.1 BrightGene Bio-Medical ADC Drug Substance Company Information
7.4.2 BrightGene Bio-Medical ADC Drug Substance Product Portfolio
7.4.3 BrightGene Bio-Medical ADC Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.4.4 BrightGene Bio-Medical Main Business and Markets Served
7.4.5 BrightGene Bio-Medical Recent Developments/Updates
7.5 Haoyuan Pharmaceutical
7.5.1 Haoyuan Pharmaceutical ADC Drug Substance Company Information
7.5.2 Haoyuan Pharmaceutical ADC Drug Substance Product Portfolio
7.5.3 Haoyuan Pharmaceutical ADC Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Haoyuan Pharmaceutical Main Business and Markets Served
7.5.5 Haoyuan Pharmaceutical Recent Developments/Updates
7.6 Pfizer
7.6.1 Pfizer ADC Drug Substance Company Information
7.6.2 Pfizer ADC Drug Substance Product Portfolio
7.6.3 Pfizer ADC Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Pfizer Main Business and Markets Served
7.6.5 Pfizer Recent Developments/Updates
7.7 Roche
7.7.1 Roche ADC Drug Substance Company Information
7.7.2 Roche ADC Drug Substance Product Portfolio
7.7.3 Roche ADC Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Roche Main Business and Markets Served
7.7.5 Roche Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 ADC Drug Substance Industry Chain Analysis
8.2 ADC Drug Substance Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 ADC Drug Substance Production Mode & Process Analysis
8.4 ADC Drug Substance Sales and Marketing
8.4.1 ADC Drug Substance Sales Channels
8.4.2 ADC Drug Substance Distributors
8.5 ADC Drug Substance Customer Analysis
9 ADC Drug Substance Market Dynamics
9.1 ADC Drug Substance Industry Trends
9.2 ADC Drug Substance Market Drivers
9.3 ADC Drug Substance Market Challenges
9.4 ADC Drug Substance Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global ADC Drug Substance Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global ADC Drug Substance Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global ADC Drug Substance Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global ADC Drug Substance Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global ADC Drug Substance Production Market Share by Manufacturers (2020-2025)
 Table 6. Global ADC Drug Substance Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global ADC Drug Substance Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of ADC Drug Substance, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in ADC Drug Substance as of 2024)
 Table 10. Global Market ADC Drug Substance Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of ADC Drug Substance, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of ADC Drug Substance, Product Offered and Application
 Table 13. Global Key Manufacturers of ADC Drug Substance, Date of Enter into This Industry
 Table 14. Global ADC Drug Substance Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global ADC Drug Substance Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global ADC Drug Substance Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global ADC Drug Substance Production Value Market Share by Region (2020-2025)
 Table 19. Global ADC Drug Substance Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global ADC Drug Substance Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global ADC Drug Substance Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global ADC Drug Substance Production (Tons) by Region (2020-2025)
 Table 23. Global ADC Drug Substance Production Market Share by Region (2020-2025)
 Table 24. Global ADC Drug Substance Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global ADC Drug Substance Production Market Share Forecast by Region (2026-2031)
 Table 26. Global ADC Drug Substance Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global ADC Drug Substance Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global ADC Drug Substance Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global ADC Drug Substance Consumption by Region (2020-2025) & (Tons)
 Table 30. Global ADC Drug Substance Consumption Market Share by Region (2020-2025)
 Table 31. Global ADC Drug Substance Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global ADC Drug Substance Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America ADC Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America ADC Drug Substance Consumption by Country (2020-2025) & (Tons)
 Table 35. North America ADC Drug Substance Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe ADC Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe ADC Drug Substance Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe ADC Drug Substance Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific ADC Drug Substance Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific ADC Drug Substance Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific ADC Drug Substance Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa ADC Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa ADC Drug Substance Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa ADC Drug Substance Consumption by Country (2026-2031) & (Tons)
 Table 45. Global ADC Drug Substance Production (Tons) by Type (2020-2025)
 Table 46. Global ADC Drug Substance Production (Tons) by Type (2026-2031)
 Table 47. Global ADC Drug Substance Production Market Share by Type (2020-2025)
 Table 48. Global ADC Drug Substance Production Market Share by Type (2026-2031)
 Table 49. Global ADC Drug Substance Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global ADC Drug Substance Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global ADC Drug Substance Production Value Market Share by Type (2020-2025)
 Table 52. Global ADC Drug Substance Production Value Market Share by Type (2026-2031)
 Table 53. Global ADC Drug Substance Price (US$/Ton) by Type (2020-2025)
 Table 54. Global ADC Drug Substance Price (US$/Ton) by Type (2026-2031)
 Table 55. Global ADC Drug Substance Production (Tons) by Application (2020-2025)
 Table 56. Global ADC Drug Substance Production (Tons) by Application (2026-2031)
 Table 57. Global ADC Drug Substance Production Market Share by Application (2020-2025)
 Table 58. Global ADC Drug Substance Production Market Share by Application (2026-2031)
 Table 59. Global ADC Drug Substance Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global ADC Drug Substance Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global ADC Drug Substance Production Value Market Share by Application (2020-2025)
 Table 62. Global ADC Drug Substance Production Value Market Share by Application (2026-2031)
 Table 63. Global ADC Drug Substance Price (US$/Ton) by Application (2020-2025)
 Table 64. Global ADC Drug Substance Price (US$/Ton) by Application (2026-2031)
 Table 65. TOT Biopharm International ADC Drug Substance Company Information
 Table 66. TOT Biopharm International ADC Drug Substance Specification and Application
 Table 67. TOT Biopharm International ADC Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. TOT Biopharm International Main Business and Markets Served
 Table 69. TOT Biopharm International Recent Developments/Updates
 Table 70. Lonza Group AG ADC Drug Substance Company Information
 Table 71. Lonza Group AG ADC Drug Substance Specification and Application
 Table 72. Lonza Group AG ADC Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Lonza Group AG Main Business and Markets Served
 Table 74. Lonza Group AG Recent Developments/Updates
 Table 75. WuXi XDC Cayman ADC Drug Substance Company Information
 Table 76. WuXi XDC Cayman ADC Drug Substance Specification and Application
 Table 77. WuXi XDC Cayman ADC Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. WuXi XDC Cayman Main Business and Markets Served
 Table 79. WuXi XDC Cayman Recent Developments/Updates
 Table 80. BrightGene Bio-Medical ADC Drug Substance Company Information
 Table 81. BrightGene Bio-Medical ADC Drug Substance Specification and Application
 Table 82. BrightGene Bio-Medical ADC Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. BrightGene Bio-Medical Main Business and Markets Served
 Table 84. BrightGene Bio-Medical Recent Developments/Updates
 Table 85. Haoyuan Pharmaceutical ADC Drug Substance Company Information
 Table 86. Haoyuan Pharmaceutical ADC Drug Substance Specification and Application
 Table 87. Haoyuan Pharmaceutical ADC Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Haoyuan Pharmaceutical Main Business and Markets Served
 Table 89. Haoyuan Pharmaceutical Recent Developments/Updates
 Table 90. Pfizer ADC Drug Substance Company Information
 Table 91. Pfizer ADC Drug Substance Specification and Application
 Table 92. Pfizer ADC Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Pfizer Main Business and Markets Served
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Roche ADC Drug Substance Company Information
 Table 96. Roche ADC Drug Substance Specification and Application
 Table 97. Roche ADC Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Roche Main Business and Markets Served
 Table 99. Roche Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. ADC Drug Substance Distributors List
 Table 103. ADC Drug Substance Customers List
 Table 104. ADC Drug Substance Market Trends
 Table 105. ADC Drug Substance Market Drivers
 Table 106. ADC Drug Substance Market Challenges
 Table 107. ADC Drug Substance Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of ADC Drug Substance
 Figure 2. Global ADC Drug Substance Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global ADC Drug Substance Market Share by Type: 2024 VS 2031
 Figure 4. ADC Drug Substance Targeting Nectin-4 Product Picture
 Figure 5. ADC Drug Substance Targeting Trop-2 Product Picture
 Figure 6. Global ADC Drug Substance Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global ADC Drug Substance Market Share by Application: 2024 VS 2031
 Figure 8. Drug R&D
 Figure 9. Medical Research
 Figure 10. Others
 Figure 11. Global ADC Drug Substance Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global ADC Drug Substance Production Value (US$ Million) & (2020-2031)
 Figure 13. Global ADC Drug Substance Production Capacity (Tons) & (2020-2031)
 Figure 14. Global ADC Drug Substance Production (Tons) & (2020-2031)
 Figure 15. Global ADC Drug Substance Average Price (US$/Ton) & (2020-2031)
 Figure 16. ADC Drug Substance Report Years Considered
 Figure 17. ADC Drug Substance Production Share by Manufacturers in 2024
 Figure 18. Global ADC Drug Substance Production Value Share by Manufacturers (2024)
 Figure 19. ADC Drug Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by ADC Drug Substance Revenue in 2024
 Figure 21. Global ADC Drug Substance Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global ADC Drug Substance Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global ADC Drug Substance Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 24. Global ADC Drug Substance Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America ADC Drug Substance Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Europe ADC Drug Substance Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. China ADC Drug Substance Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Japan ADC Drug Substance Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Global ADC Drug Substance Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 30. Global ADC Drug Substance Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 31. North America ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 32. North America ADC Drug Substance Consumption Market Share by Country (2020-2031)
 Figure 33. U.S. ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Canada ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. Europe ADC Drug Substance Consumption Market Share by Country (2020-2031)
 Figure 37. Germany ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. France ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. U.K. ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Italy ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Russia ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Asia Pacific ADC Drug Substance Consumption Market Share by Region (2020-2031)
 Figure 44. China ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Japan ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. South Korea ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. China Taiwan ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. Southeast Asia ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. India ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Latin America, Middle East & Africa ADC Drug Substance Consumption Market Share by Country (2020-2031)
 Figure 52. Mexico ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Brazil ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Turkey ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. GCC Countries ADC Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. Global Production Market Share of ADC Drug Substance by Type (2020-2031)
 Figure 57. Global Production Value Market Share of ADC Drug Substance by Type (2020-2031)
 Figure 58. Global ADC Drug Substance Price (US$/Ton) by Type (2020-2031)
 Figure 59. Global Production Market Share of ADC Drug Substance by Application (2020-2031)
 Figure 60. Global Production Value Market Share of ADC Drug Substance by Application (2020-2031)
 Figure 61. Global ADC Drug Substance Price (US$/Ton) by Application (2020-2031)
 Figure 62. ADC Drug Substance Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart